A comment on one of my Graph Blockchain (GBLC.C) stories from earlier this month made me stop and think.
Harvest Medicine, a subsidiary of VIVO Cannabis (VIVO.V), has just released a new telemedicine app which could help bridge the long-troublesome gap between cannabis companies and insurance providers.
About a year back, I told you guys about a telemedicine company called Reliq Health Technologies (RHT.V). You didn’t pay much attention because it was little and new and ‘telemedicine’ sounds like a Home Shopping Channel show at 2am that sells Acai supplements.
Back when it was dragging its ass along the road at $0.10 a share, we told you – again and again – that Reliq Health Technologies (RHT.V) was doing actual business with a big fat upside.
A while back I wrote about a little company called (among other things) Reliq Health Technologies (RHT.V). The company started as one thing (mobile security), shifted to another (tracking and networking health care equipment) before eventually evolving into a telemedicine tech play.
I’ve taken a lot of crap from folks over the last year for writing positive things about medical tech firm Reliq Health Technologies (RHT.V). but today I’m retaliating with a hefty can of ToldYaSo, because RHT announced a deal that, frankly, is their gamechanger.
Equity.Guru friends Reliq Health Technologies (RHT.V) have dropped some solid news, that they’ve been accepted into the UK National Health Service’s ‘Test Beds’ program, to run a pilot test in a London-area hospital in Q4.
Reliq Health Technologies (RHT.V) CEO Lisa Crossley is crushing it right now, which isn’t a surprise to anyone who has talked to her. A four-time health tech entrepreneur who has raised millions and seen to healthy exits, publicly and privately, she’s convinced Reliq will be the jewel in her career crown.